OpenCareby Vivonco
Search/
Talk to us Review a case
Menu
Skip to content
A cluster of breast cancer cells seen under an electron microscope

Facing cancer? We'll help you find your way.

Share your reports. Get a clear plan: the right treatments, tests, doctors and help to pay.

Get your plan
  • 25,000+cancer specialists
  • 3,500+hospitals
  • 470+ways to pay

From your report to your plan

Pathology report Example
  1. INVASIVE DUCTAL CARCINOMA, GRADE 2
  2. Tumor size: 2.4 cm
  3. pT2 pN1a (2/14 lymph nodes positive)1
  4. ER: Positive (95%) PR: Positive (20%)2
  5. HER2: IHC 1+2
  6. Ki-67: 25%
Your plan Example
1Stage
Early breast cancer. It has spread to 2 nearby lymph nodes.
2Test results
Hormone receptor-positive. HER2-low.
3Missing
Menopause status is not on your reports.
4To ask
Would a recurrence score test change my treatment?

A second look at your reports

The usual path for your cancer and stage

The usual treatment steps, and which ones you've had.

Tests that could change the plan

Tests your reports don't have yet, and why they matter.

Medicines and help to pay

Which are FDA approved, and programs that help you pay.

Trials you could join

Open trials that fit you, closest to home first.

Get your plan

Tested in the open

Trial matching 97%

The trial NCI investigators chose was in our top 10 for 97% of their 41 test cases. The best published result is 70%.

NIH-TrialBench
FDA approvals 100%

We tested 798 FDA cancer indications. "Approved" showed only when the cancer, the marker and the treatment line all fit.

FDA drug labels
Every plan is checked against
  • 800+FDA cancer indications
  • 2,400+CIViC evidence items
  • 4live trial registries

The registries are ClinicalTrials.gov, EU CTIS, ISRCTN and CRIS. Each one is searched live.

Reading reports 99.9%

Hormone receptor, HER2 and lymph node results were read right 99.9% of the time in 9,523 real pathology reports.

TCGA-Reports, NCI
Get your plan